Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units

Nephrology Dialysis Transplantation

Volumn 11, Issue 10, 1996, Pages 2017-2022

  Pinto Dos Santos, J ^a   Loureiro, A ^a   Cendoroglo Neto, M ^b   Pereira, B J G ^b  

^a Portuguese Society of Nephrology   (Portugal)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Dialysis complications; Haemodialysis; Hepatitis C; Reuse

Indexed keywords

HEPATITIS C ANTIBODY;

ARTICLE; GEOGRAPHIC DISTRIBUTION; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SOCIOECONOMICS; VIRUS TRANSMISSION;

EID: 0029954146     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027090     Document Type: Article

References (28)

1. Tokars J, Alter MJ, Favero MS et al. National surveillance of hemodialysis associated diseases in the United States, 1992. ASAIO J 1994; 40: 1020-1031
2. Natov SN, Pereira BJG. Hepatitis C infection in patients on dialysis. Semin Dial 1994; 7: 360-368
3. Pereira BJG. Hepatitis C infection and post-transplantation liver disease [Review]. Nephrol Dial Transplant 1995; 10: 58-67
4. Valderrábano F, Jones EHP, Mallick NP. Report on management of renal failure in Europe, XXIV. 1993. Nephrol Dial Transplant 1995; 10(suppl 5): 1-25
5. Esteban JI, Esteban R, Viladomiu L et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; ii: 294-296
6. Pereira BJG, Milford EL, Kirkman RL et al. Prevalence of HCV RNA in hepatitis C antibody positive cadaver organ donors and their recipients. N Engl J Med 1992; 327: 910-915
7. Donahue JG, Muñoz A, Ness PM et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-373
8. Yoshizawa H, Otoh Y, Iwakiri K, Tanaka A, Tachibana T. Non-A, non-B (type 1) hepatitis agent capable of inducing tubular structures in the hepatocyte cytoplasm of chimpanzees: inactivation by formalin and heat. Gastroenterology 1982; 82: 502-506
9. Farci P, Alter HJ. Govindarajan S et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135-140
10. Carrera F, Silva JG, Oliveira C, Frazao JM, Pires C. Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population. Nephron 1994; 68: 38-40
11. Huraib S, Al-Rashed R, Aldrees A, Aljefry M, Arif M, AI-Faleh FA. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 1995; 10: 470-474
12. Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody for hepatitis C virus. Am J Kidney Dis 1992; 19: 345-352
13. Garcia-Valdescasas J, Bernai MC, Cerezo S, Garcia F, Pereira BJG. Strategies to reduce the transmission of HCV infection in hemodialysis (HD) units [abstract]. J Am Soc Nephrol 1993; 4: 347
14. Vagelli G, Calabrese G, Guaschino R, Gonella M. Effect of HCV+ patients isolation on HCV infection incidence in a dialysis unit. Nephrol Dial Transplant 1992; 7: 1070
15. Sampietro M, Badalamenti S, Salvadori S et al. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int 1995; 47: 911-917
16. Stuyver L, Caleys H, Wyseur A et al. Hepatitis C virus in a hemodialysis unit: molecular evidence for nososcomial transmission. Kidney Int 1996; 889-895
17. Jadoul M, Cornu C, Van Ypersele de Strihou C, the UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. Kidney Int 1993; 44: 1322-1326
18. Da Porto A, Adami A, Susanna F et al. Hepatitis C virus in dialysis units: a multicenter study. Nephron 1992; 61: 309-310
19. Gilli P, Soffritti S, Vitali EDP, Bedani PL. Prevention of hepatitis C virus in dialysis units. Nephron 1995; 70: 301-306
20. Fabrizi F, Lunghi G, Guarnori I et al. Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study. Nephrol Dial Transplant 1994; 9: 1611-1615
21. Zeuzem S, Scheuermann EH, Waschk D et al. Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients. Kidney Int 1996; 49: 896-902
22. Moyer LA, Alter MJ. Hepatitis C virus in the hemodialysis setting: a review with recommendations for control. Semin Dial 1994; 7: 124-127
23. Gilli P, Moretti M, Soffritti S et al. Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients, Int J Artif Organs 1990; 13: 737-741
24. Okuda K, Hayashi H, Yokozeki K et al. Mode of nosocomial HCV infection among chronic hemodialysis patients and its prevention. Hepatology 1994; 19: 293
25. Yuasa T, Ishikawa G, Manabe S, Sekiguchi S, Takeuchi K, Miyamura T. The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre. J Gen Virol 1991; 72: 2021-2024
26. Caramelo C, Navas S, Alberola ML et al. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66: 470-473
27. Hubmann R, Zazgornik J, Gabriel C et al. Hepatitis C virus-does it penetrate the haemodialysis membrane? PCR analysis of haemodialysis ultrafiltrate and whole blood. Nephrol Dial Transplant 1995; 10: 541-542
28. Lombardi M, Cerrai T, Dattolo P et al. Is the dialysis membrane a safe barrier against HCV infection? Nephrol Dial Transplant 1995; 10: 578-579